[go: up one dir, main page]

WO2005044075A3 - Compositions, variantes d'epissures, et procedes se rapportant a des genes et proteines specifiques du sein - Google Patents

Compositions, variantes d'epissures, et procedes se rapportant a des genes et proteines specifiques du sein Download PDF

Info

Publication number
WO2005044075A3
WO2005044075A3 PCT/US2004/030719 US2004030719W WO2005044075A3 WO 2005044075 A3 WO2005044075 A3 WO 2005044075A3 US 2004030719 W US2004030719 W US 2004030719W WO 2005044075 A3 WO2005044075 A3 WO 2005044075A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
breast
compositions
antagonists
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/030719
Other languages
English (en)
Other versions
WO2005044075A2 (fr
Inventor
Roberto A Macina
Leah R Turner
Yongming Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Publication of WO2005044075A2 publication Critical patent/WO2005044075A2/fr
Anticipated expiration legal-status Critical
Publication of WO2005044075A3 publication Critical patent/WO2005044075A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des molécules d'acides nucléiques et de polypeptides récemment identifiés, présents dans des cellules normales et néoplasiques du sein, y compris des fragments, des variantes et des dérivés de ces acides nucléiques et polypeptides. L'invention concerne également des anticorps dirigés contre les polypeptides de l'invention, ainsi que des agonistes et antagonistes des polypeptides de l'invention. L'invention concerne encore des compositions contenant ces molécules d'acides nucléiques, polypeptides, anticorps, agonistes et antagonistes, ainsi que les procédés d'utilisation correspondants. Les utilisations englobent l'identification, le diagnostic, la surveillante, la stadification et le traitement du cancer du sein ainsi que des états pathologiques non-cancéreux affectant le sein, l'identification des tissus du sein, la surveillance et l'identification et/ou la conception d'agonistes et d'antagonistes des polypeptides de l'invention. L'invention concerne enfin la thérapie génique, la production d'animaux et cellules transgéniques, ainsi que la production de tissus issus du génie génétique pour des applications thérapeutiques et de recherche.
PCT/US2004/030719 2003-09-19 2004-09-20 Compositions, variantes d'epissures, et procedes se rapportant a des genes et proteines specifiques du sein Ceased WO2005044075A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50478103P 2003-09-19 2003-09-19
US60/504,781 2003-09-19

Publications (2)

Publication Number Publication Date
WO2005044075A2 WO2005044075A2 (fr) 2005-05-19
WO2005044075A3 true WO2005044075A3 (fr) 2009-04-02

Family

ID=34572741

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/030719 Ceased WO2005044075A2 (fr) 2003-09-19 2004-09-20 Compositions, variantes d'epissures, et procedes se rapportant a des genes et proteines specifiques du sein

Country Status (1)

Country Link
WO (1) WO2005044075A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5531228B2 (ja) * 2008-03-28 2014-06-25 静岡県 高転移性胃癌マーカー

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001049A2 (fr) * 1990-07-13 1992-01-23 The General Hospital Corporation Antigene de surface de cellule cd53 et son utilisation
US20010004494A1 (en) * 1997-09-27 2001-06-21 Bernhard Mussig Self-adhesive protective film with olefin rubber adhesive

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001049A2 (fr) * 1990-07-13 1992-01-23 The General Hospital Corporation Antigene de surface de cellule cd53 et son utilisation
US20010004494A1 (en) * 1997-09-27 2001-06-21 Bernhard Mussig Self-adhesive protective film with olefin rubber adhesive

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANGELISOVA ET AL.: "The Human Leucocyte Surface Antigen CD53 is a Protein Structurally Similar to the CD 37 and MRC OX-44 Antigens", IMMUNOGENTICS, vol. 32, 1990, pages 281 - 285 *
KORINEK ET AL.: "Genomic Structure of the Human CD 53 Gene", IMMUOGENTICS, vol. 38, 1993, pages 272 - 279 *
POUSTKA ET AL.: "Selective Isolation ofCosmid Clones by Homologous Recombination in Escherichia coli", PROC. NATL. ACAD. SCI. USA, vol. 81, July 1984 (1984-07-01), pages 4129 - 4133 *
STRATAGENE CATALOG., 1998, pages 39 *

Also Published As

Publication number Publication date
WO2005044075A2 (fr) 2005-05-19

Similar Documents

Publication Publication Date Title
WO2004053079A3 (fr) Compositions, variants d'epissage et methodes concernant des genes et des proteines specifiques des ovaires
WO2004092338A3 (fr) Compositions, variants d'epissage et procedes concernant des genes et des proteines specifiques du cancer
WO2002062945A3 (fr) Compositions et techniques relatives a des genes et a des proteines specifiques du poumon
WO2002040672A3 (fr) Compositions et methodes relatives a des genes et des proteines specifiques aux seins
WO2002064741A3 (fr) Compositions et methodes concernant des genes et des proteines specifiques du sein
WO2004050860A3 (fr) Compositions, variants d'epissage et methodes associes aux genes et proteines specifiques du colon
WO2002040673A3 (fr) Compositions et methodes relatives a des genes et des proteines specifiques aux poumons
WO2004053075A3 (fr) Compositions, variants d'epissage et procedes relatifs a des genes et des proteines specifiques du sein
WO2002077232A3 (fr) Compositions et methodes relatives a des genes et a des proteines specifiques du sein
WO2005017102A3 (fr) Compositions, variants d'epissage et procedes associes a des acides nucleiques et des proteines specifiques
WO2004013311A3 (fr) Compositions et methodes se rapportant a des genes et proteines specifiques de l'ovaire
WO2004050858A3 (fr) Compositions, variants d'epissage et procedes associe aux genes et proteines specifiques du colon
WO2002064788A3 (fr) Compositions et procedes relatifs aux genes et aux proteines specifiques aux poumons
WO2003066877A3 (fr) Compositions et procedes se rapportant a des genes et proteines specifiques hepatiques
WO2004052290A3 (fr) Compositions, variants d'epissage et procedes concernant des genes et proteines specifiques du sein
WO2004053077A3 (fr) Compositions, variants d'epissure et techniques liees aux genes et aux proteines specifiques du sein
WO2002068645A3 (fr) Compositions et procedes concernant des genes et des proteines specifiques pour le sein
WO2003020953A3 (fr) Compositions et procedes concernant des genes et des proteines specifiques du colon
WO2003020899A3 (fr) Compositions et methodes relatives a des genes et proteines specifiques des poumons
WO2007001399A3 (fr) Compositions, variants d'epissage et methodes relatifs aux genes et aux proteines specifiques du cancer
WO2004053081A3 (fr) Compositions, variants a epissure et methodes associees aux proteines et genes specifiques de la prostate
WO2003020897A3 (fr) Compositions et procedes concernant des genes et des proteines specifiques des ovaires
WO2002066605A3 (fr) Compositions et procedes relatifs a des genes et a des proteines specifiques du sein
WO2005044075A3 (fr) Compositions, variantes d'epissures, et procedes se rapportant a des genes et proteines specifiques du sein
WO2002048370A3 (fr) Compositions et methodes associees a des genes et a des proteines specifiques du colon

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase